“…When tested by immunohistochemistry the prostatic stromal cells are positive for androgen and progesterone receptors but not for estrogen receptors. [1][2][3] Many authors described lesions arising from the specialized prostatic stroma under several designations, including atypical stromal hyperplasia, 4,5 atypical stromal smooth muscle hyperplasia, 6 atypical fibromuscular hyperplasia, 7 phyllodes type of hyperplasia, [8][9][10][11][12] phyllodes tumor, 7,12-17 cystadeno-leiomyofibroma, 18 prostatic cystic epithelial stromal tumor, 19 cystosarcoma phyllodes, [20][21][22][23][24][25][26] pseudosarcomatous lesions of the prostate, 27 malignant phyllodes tumor of the prostate, 14,15,22,23,28,29 and stromal sarcoma of the prostate. 30 Gaudin and colleagues reported their experience with 22 tumors of the specialized prostatic stroma and proposed a unifying concept under which many of the previously described entities could be included.…”